Sign Up
OverviewAPI
DZS Inc. is facing a securities class action lawsuit alleging false and misleading statements about its financial reporting. Hagens Berman is urging investors to submit their losses and focusing on the propriety of DZS's accounting and internal controls. Nymox CEO is being challenged by a committee to restore shareholder value by publishing the 2022 FDA refusal to file correspondence.

Ask a question